Version 1
: Received: 11 January 2018 / Approved: 11 January 2018 / Online: 11 January 2018 (04:01:57 CET)
How to cite:
Dang, Y.; Wang, X.; Cen, Y.; Hong, Y.; Huang, P.; Loewen, N.; Zhang, C. Two-Year Outcomes of Ab Interno Trabeculectomy with the Trabectome for Chinese Primary Open Angle Glaucoma: A Retrospective Multicenter Study. Preprints2018, 2018010096. https://doi.org/10.20944/preprints201801.0096.v1
Dang, Y.; Wang, X.; Cen, Y.; Hong, Y.; Huang, P.; Loewen, N.; Zhang, C. Two-Year Outcomes of Ab Interno Trabeculectomy with the Trabectome for Chinese Primary Open Angle Glaucoma: A Retrospective Multicenter Study. Preprints 2018, 2018010096. https://doi.org/10.20944/preprints201801.0096.v1
Dang, Y.; Wang, X.; Cen, Y.; Hong, Y.; Huang, P.; Loewen, N.; Zhang, C. Two-Year Outcomes of Ab Interno Trabeculectomy with the Trabectome for Chinese Primary Open Angle Glaucoma: A Retrospective Multicenter Study. Preprints2018, 2018010096. https://doi.org/10.20944/preprints201801.0096.v1
APA Style
Dang, Y., Wang, X., Cen, Y., Hong, Y., Huang, P., Loewen, N., & Zhang, C. (2018). Two-Year Outcomes of Ab Interno Trabeculectomy with the Trabectome for Chinese Primary Open Angle Glaucoma: A Retrospective Multicenter Study. Preprints. https://doi.org/10.20944/preprints201801.0096.v1
Chicago/Turabian Style
Dang, Y., Nils Loewen and Chun Zhang. 2018 "Two-Year Outcomes of Ab Interno Trabeculectomy with the Trabectome for Chinese Primary Open Angle Glaucoma: A Retrospective Multicenter Study" Preprints. https://doi.org/10.20944/preprints201801.0096.v1
Abstract
To evaluate the 2-year efficacy and safety of ab interno trabeculectomy with the Trabectome in Chinese primary open-angle glaucoma (POAG) patients. This was a multicenter, retrospective study and included POAG patients with or without visually-significant cataracts. The primary outcome was intraocular pressure (IOP) reduction. Secondary outcomes included reduction of glaucoma medications, surgical complications, and success at 2-years. Success was defined as: 1) IOP < 21 mmHg and at least 20% IOP reduction from baseline after 3 months at any two consecutive visits, and 2) no additional glaucoma surgery required. A total of 42 patients were enrolled; thirteen had a history of failed glaucoma surgery. Twelve patients underwent Trabectome surgery combined with phacoemulsification while the remainder underwent Trabectome surgery alone. Overall, the mean preoperative IOP was 21.4±1.23 mmHg. The Trabectome lowered IOP to 18.5± 0.94 mmHg at 2 years (P<0.05). The number of glaucoma medications also decreased from a baseline of 2.0±0.9 to 1.2± 0.21 at 2 years (P=0.04). The overall success was 78%, with patients undergoing combined surgery having a higher success than those with Trabectome surgery alone (100% vs. 76%). No major complications were seen. The Trabectome appears to be an efficient and safe procedure in Chinese POAG patients in the long-term.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
